GNA14
Basic information
Region (hg38): 9:77423079-77648322
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Congenital tufted angioma;Pyogenic granuloma;Kaposiform hemangioendothelioma (1 variants)
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GNA14 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 20 | 22 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 1 | 0 | 20 | 0 | 3 |
Variants in GNA14
This is a list of pathogenic ClinVar variants found in the GNA14 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-77423996-C-T | not specified | Uncertain significance (Feb 14, 2023) | ||
9-77425594-G-C | not specified | Uncertain significance (May 05, 2022) | ||
9-77425622-C-G | Cerebrofacial arteriovenous metameric syndrome • not specified | Uncertain significance (Mar 19, 2024) | ||
9-77425661-A-G | not specified | Uncertain significance (Mar 18, 2024) | ||
9-77425709-T-C | not specified | Uncertain significance (Jan 09, 2024) | ||
9-77425711-C-G | not specified | Uncertain significance (May 08, 2024) | ||
9-77425711-C-T | not specified | Uncertain significance (Sep 23, 2023) | ||
9-77425712-G-A | not specified | Uncertain significance (Jun 19, 2024) | ||
9-77428951-CA-C | High myopia | Uncertain significance (Dec 17, 2018) | ||
9-77429002-G-A | not specified | Uncertain significance (Feb 28, 2023) | ||
9-77429007-T-C | not specified | Uncertain significance (Aug 22, 2023) | ||
9-77429016-T-A | Congenital tufted angioma;Pyogenic granuloma;Kaposiform hemangioendothelioma | Pathogenic (May 12, 2021) | ||
9-77431365-G-A | Benign (Dec 31, 2019) | |||
9-77431409-C-T | not specified | Uncertain significance (Feb 27, 2024) | ||
9-77431430-G-A | not specified | Uncertain significance (Dec 02, 2022) | ||
9-77431445-G-C | not specified | Uncertain significance (Jun 16, 2024) | ||
9-77434396-C-G | not specified | Uncertain significance (May 01, 2024) | ||
9-77434432-C-T | not specified | Uncertain significance (May 10, 2022) | ||
9-77434476-A-G | Tufted angioma of skin | Uncertain significance (Aug 21, 2023) | ||
9-77434492-C-T | not specified | Uncertain significance (Feb 07, 2023) | ||
9-77529071-T-C | not specified | Uncertain significance (Nov 05, 2021) | ||
9-77529120-C-T | not specified | Uncertain significance (Jan 04, 2024) | ||
9-77529145-T-C | not specified | Uncertain significance (Oct 22, 2021) | ||
9-77529146-T-C | not specified | Uncertain significance (May 31, 2023) | ||
9-77529151-T-C | not specified | Uncertain significance (Apr 23, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GNA14 | protein_coding | protein_coding | ENST00000341700 | 7 | 225229 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.43e-17 | 0.00113 | 125576 | 0 | 172 | 125748 | 0.000684 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.384 | 215 | 200 | 1.08 | 0.0000109 | 2346 |
Missense in Polyphen | 78 | 76.162 | 1.0241 | 965 | ||
Synonymous | -0.838 | 84 | 74.8 | 1.12 | 0.00000423 | 645 |
Loss of Function | -0.894 | 23 | 18.8 | 1.22 | 9.81e-7 | 212 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000485 | 0.000484 |
Ashkenazi Jewish | 0.00159 | 0.00159 |
East Asian | 0.000598 | 0.000598 |
Finnish | 0.000416 | 0.000416 |
European (Non-Finnish) | 0.000988 | 0.000985 |
Middle Eastern | 0.000598 | 0.000598 |
South Asian | 0.000394 | 0.000392 |
Other | 0.000331 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems.;
- Pathway
- Amoebiasis - Homo sapiens (human);Chagas disease (American trypanosomiasis) - Homo sapiens (human);Calcium signaling pathway - Homo sapiens (human);G Protein Signaling Pathways;Signaling by GPCR;Signal Transduction;Thromboxane signalling through TP receptor;Metabolism;Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion;Acetylcholine regulates insulin secretion;Free fatty acids regulate insulin secretion;Regulation of insulin secretion;Signal amplification;Thrombin signalling through proteinase activated receptors (PARs);Platelet activation, signaling and aggregation;ADP signalling through P2Y purinoceptor 1;Hemostasis;Thromboxane A2 receptor signaling;Integration of energy metabolism;G alpha (q) signalling events;GPCR downstream signalling;PAR4-mediated thrombin signaling events;PAR1-mediated thrombin signaling events;LPA receptor mediated events;IL8- and CXCR1-mediated signaling events;S1P3 pathway;Arf6 signaling events;Plasma membrane estrogen receptor signaling;Sphingosine 1-phosphate (S1P) pathway;Endothelins;IL8- and CXCR2-mediated signaling events;S1P2 pathway
(Consensus)
Recessive Scores
- pRec
- 0.140
Intolerance Scores
- loftool
- 0.372
- rvis_EVS
- -0.13
- rvis_percentile_EVS
- 43.91
Haploinsufficiency Scores
- pHI
- 0.314
- hipred
- N
- hipred_score
- 0.493
- ghis
- 0.502
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.237
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gna14
- Phenotype
Gene ontology
- Biological process
- signal transduction;G protein-coupled receptor signaling pathway;adenylate cyclase-modulating G protein-coupled receptor signaling pathway;platelet activation;phospholipase C-activating dopamine receptor signaling pathway
- Cellular component
- heterotrimeric G-protein complex;plasma membrane;extracellular exosome
- Molecular function
- G protein-coupled receptor binding;GTPase activity;protein binding;GTP binding;G-protein beta/gamma-subunit complex binding;metal ion binding